Profound Medical Corp is a medical technology company focused on transforming the treatment of prostate cancer through innovative solutions
The company develops and commercializes a proprietary system that combines real-time imaging and targeted ultrasound to provide a minimally invasive treatment option for patients. This approach aims to improve patient outcomes by delivering precise therapy while minimizing side effects associated with traditional surgical methods. Profound Medical is committed to advancing the field of urology by leveraging its advanced technology platform to enhance cancer care and improve the quality of life for patients.
Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Profound Medical (NASDAQ:PROF) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Profound Medical will report an earnings per share (EPS) of $-0.43.
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.
XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...
Profound Medical (NASDAQ:PROF) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...
